State Street’s Immune Design Corp. IMDZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-597,011
| Closed | -$3.49M | – | 3919 |
|
|
2019
Q1 | $3.49M | Sell |
597,011
-64,765
| -10% | -$221K | ﹤0.01% | 2922 |
|
|
2018
Q4 | $860K | Buy |
661,776
+109,242
| +20% | +$190K | ﹤0.01% | 3356 |
|
|
2018
Q3 | $1.9M | Buy |
552,534
+86,375
| +19% | +$324K | ﹤0.01% | 3264 |
|
|
2018
Q2 | $2.12M | Buy |
466,159
+73,326
| +19% | +$292K | ﹤0.01% | 3232 |
|
|
2018
Q1 | $1.3M | Buy |
392,833
+151,155
| +63% | +$535K | ﹤0.01% | 3297 |
|
|
2017
Q4 | $942K | Buy |
241,678
+20,188
| +9% | +$110K | ﹤0.01% | 3366 |
|
|
2017
Q3 | $2.29M | Sell |
221,490
-2,542
| -1% | -$25K | ﹤0.01% | 3145 |
|
|
2017
Q2 | $2.18M | Sell |
224,032
-992
| -0.4% | -$6.96K | ﹤0.01% | 3099 |
|
|
2017
Q1 | $1.53M | Sell |
225,024
-12,539
| -5% | -$72.5K | ﹤0.01% | 3176 |
|
|
2016
Q4 | $1.31M | Buy |
237,563
+18,115
| +8% | +$128K | ﹤0.01% | 3227 |
|
|
2016
Q3 | $1.67M | Buy |
219,448
+11,778
| +6% | +$86.1K | ﹤0.01% | 3042 |
|
|
2016
Q2 | $1.69M | Buy |
207,670
+39,551
| +24% | +$493K | ﹤0.01% | 3094 |
|
|
2016
Q1 | $2.19M | Buy |
168,119
+43,026
| +34% | +$497K | ﹤0.01% | 2973 |
|
|
2015
Q4 | $2.51M | Buy |
125,093
+16,404
| +15% | +$283K | ﹤0.01% | 2906 |
|
|
2015
Q3 | $1.32M | Buy |
108,689
+22,640
| +26% | +$424K | ﹤0.01% | 3147 |
|
|
2015
Q2 | $1.77M | Buy |
86,049
+12,185
| +16% | +$288K | ﹤0.01% | 3098 |
|
|
2015
Q1 | $1.56M | Buy |
73,864
+8,622
| +13% | +$225K | ﹤0.01% | 3114 |
|
|
2014
Q4 | $2.01M | Buy |
65,242
+22,342
| +52% | +$621K | ﹤0.01% | 3041 |
|
|
2014
Q3 | $757K | Buy |
+42,900
| New | +$543K | ﹤0.01% | 3316 |
|
State Street's IMDZ Position: Q2 2019 in Review
State Street sold out of Immune Design Corp. (IMDZ) in Q2 2019, closing a stake of 597,011 shares — an estimated $3.49M sold.
State Street first reported a position in IMDZ in Q3 2014 and held it in 19 quarters. The position peaked at $3.49M in Q1 2019. 0 funds tracked by Wall St. Rank hold IMDZ as of Q2 2019.
- State Street reported no remaining Immune Design Corp. position as of Q2 2019 after selling out during the quarter.
- State Street sold 597,011 Immune Design Corp. shares in Q2 2019, an estimated $3.49M.
- State Street first reported a position in Immune Design Corp. in Q3 2014 and held it in 19 quarters.
- State Street's Immune Design Corp. position peaked at $3.49M in Q1 2019.
- 0 funds tracked by Wall St. Rank held Immune Design Corp. as of Q2 2019.
Based on State Street's 13F filing for Q2 2019, filed 14 Aug 2019.